+44-20-4587-4809
Department of Pharmacology, University of California, San Francisco, USA
Commentary Article Preclinical Studies in Rare Disease Drug Development Author(s): Clauda Hartnarft* DOI: 10.35248/jpr.23.7.189
HTML PDF